Home

electronic Severity Scoring of

Atopic Dermatitis

 

eSCORAD

 

Atopic dermatitis assessment made

easy and quick 

 

The following versions of the eSCORAD are available

 

Impact of atopic dermatitis

 

Atopic eczema is an inflammatory skin condition characterized by patches of red, cracked, oozy or leathery skin.

 

The condition is chronic, prone to relapse, and often extremely pruritic. While atopic eczema may occur at any age, it is most common in childhood and severity varies throughout the life cycle. The exact cause is unclear, but it is known to result from a combination of genetic (hereditary) and environmental factors. Atopic eczema has a severely negative effect on quality of life (QoL), with patients reporting skin damage, soreness, sleep deprivation (due to itching), activity restriction and depression. The lifestyle burden should also not be underestimated with frequent doctor visits, special clothing and the need to constantly apply messy topical ointments adding to the patient distress.

 

Children with severe cases tend to have a smaller social circle and participate in fewer group activities than their peers. They are also at higher risk for developing depression, anxiety and other mental health disorders.

 

The burden is carried by parents, who report of a lack of sleep and privacy (often due to co-sleeping), treatment-related financial expenditures, and feelings of hopelessness, guilt, and depression. It is estimated that parents of children with moderate to severe atopic eczema spend up to 3 hours a day caring for their children's skin.

 

Features

use icon escorad

USER-FRIENDLY

The eSCORAD is straight-forward to use with clear diagrams for the classification of atopic dermatitis spread and severity. SCORAD can be used by clinicians from a range of different disciplines.

calculate icon escorad

HOLISTIC ASSESSMENT

The eSCORAD is a holistic measure of both the subjective and objective parameters of atopic dermatitis.

nature icon escorad

ENVIRONMENTALLY FRIENDLY

Take care of the environment and save your patient data on the online platform or as PDF files for yourself and your physicians.

patient icon escorad

QUICK

The eSCORAD consists of only 3 sections, which are quick and easy to complete due to the intuitive layout.

platform icon escorad

ACCESSIBLE FROM ALL DEVICES

With DermaValue, your eSCORAD is always just a few clicks away. The application is available for PCs, tablets, smartphones, and other devices.

 

 

References

 

Validity study:

Kunz, B., Oranje, A. P., Labrèze, L., Stalder, J. F., Ring, J., & Taïeb, A. (1997). Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology (Basel, Switzerland)195(1), 10–19. https://doi.org/10.1159/000245677

 

Rullo, V. E., Segato, A., Kirsh, A., & Sole, D. (2008). Severity scoring of atopic dermatitis: a comparison of two scoring systems. Allergologia et immunopathologia36(4), 205–211.

 

Minimal Clinically Important Difference (MCID):

Schram, M. E., Spuls, P. I., Leeflang, M. M., Lindeboom, R., Bos, J. D., & Schmitt, J. (2012). EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference. Allergy, 67(1), 99–106. https://doi.org/10.1111/j.1398-9995.2011.02719.x

 

Silverberg, J. I., Lei, D., Yousaf, M., Janmohamed, S. R., Vakharia, P. P., Chopra, R., Chavda, R., Gabriel, S., Patel, K. R., Singam, V., Kantor, R., & Hsu, D. Y. (2021). What are the best endpoints for Eczema Area and Severity Index and Scoring Atopic Dermatitis in clinical practice? A prospective observational study. The British journal of dermatology, 184(5), 888–895. https://doi.org/10.1111/bjd.19457

 

 

 

 

Our other tools

Our partners

clwaa9ujw04hh91oxg2oev665 csm ivdp 04b679b641 full
psonet logo bgwhite withpadding
cles88irj0bil0gf5qbmkfcio clahx75m800wlq891u93kod65 cvderm
ddg2
bvd
clwad8l1d002bedoxz5hxkg1g hautnetz hamburg max